Annual program will award funding to early-career healthcare professionals advancing research, education, and innovation in ...

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

WASHINGTON — Innovation in health care treatments and drug development is prompting calls for U.S. policy to contend with the biotech sector's growth, said regulators, advocates and investors at an ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology Market - Therapeutic Innovations & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. Global Biotechnology ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

Biotechnology is moving into a more commercially significant phase as scientific advances become easier to develop, manufacture and deliver. Progress in cell and gene therapy, artificial intelligence, ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series ...

Dozens of biotech executives are convening in Washington today to warn that insufficient federal policy planning could result ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

Biotechnology is increasingly important for Europe’s competitiveness, technological capabilities and economic growth. As the EU develops its policy framework for biotechnology and biomanufacturing, a ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...

Orca Bio develops cell therapies for blood cancers and autoimmune diseases, with the goal of reducing side effects and other treatment risks. Those risks are significant: Over 40% of patients who ...